Mode of Exercise and Bone Biomarkers in Older Veterans
VA Office of Research and Development · with University of Colorado, Denver · NCT05266976
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 60+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 120
- US sites recruiting
- 1
- Study start
- July 6, 2022
- Record last updated
- May 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Adults are often encouraged to exercise to maintain or improve bone health. However, there is evidence that exercise does not always lead to increases in bone mass, and exercise could lead to bone loss under certain conditions. Endurance exercise can increase bone resorption following an exercise bout, which may explain why bone does not always favorably adapt to exercise, but it is unclear if this also happens with resistance exercise. Further, it is not known how exercise training influences blood markers of bone resorption for either endurance or resistance exercise. The purpose of this study is to determine 1) if resistance exercise causes a similar increase in bone resorption as endurance exercise; and 2) if exercise training influences the increase in bone resorption following exercise for both endurance and resistance exercise.
Being studied: 10 Weeks of Supervised Resistance Exercise Training; 10 Weeks of Supervised Endurance Exercise Training
Conditions: Aging; Musculoskeletal Diseases; Osteoporosis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Healthy older (60+ y) Veteran women and men in the Denver Metro Area
- Normally active (e.g., recreational cycling or walking exercise)
Exclusion Criteria
- Impaired renal function, defined as an eGRF of \<60 mL/min/1.73m2
- Hepatobiliary disease, defined as liver function tests (AST, ALT) >1.5 times the upper limit of normal
- Thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH) \<0.5 or >5.0 mU/L
- Serum Ca \<8.5 or >10.3 mg/dL
- Serum 25(OH)D \<20 ng/mL
- Uncontrolled hypertension, defined as resting systolic blood pressure (BP) >150 mmHg or diastolic BP >90 mmHg;
- History of type 1 or type 2 diabetes
- Cardiovascular disease, defined as subjective or objective indicators of ischemic heart disease (e.g., angina, ST segment depression) or serious arrhythmias at rest or during the graded exercise test (GXT). Volunteers who have a positive GXT can be re-considered after follow-up evaluation, which must include diagnostic testing (e.g., stress echocardiogram or thallium stress test) with interpretation by a cardiologist
- Anemia, defined as a serum hemoglobin \<12.1 g/dL for women and \<14.3 g/dL for men
- Fracture in the past 6 months
- Current diagnosis or symptoms of COVID-19
In the event of abnormal BP, live function, TSH, 25(OH)D, or hemoglobin values, volunteers can be reassessed, including after appropriate follow-up evaluation and treatment by a primary care provider. Those who have experienced symptoms of COVID-19 or have been formally diagnosed will be allowed to participate once symptoms have resolved and they are approved to return to exercise by their primary care provider.
Recruiting US locations
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, CO 80045-7211
Site contact: Todd R Furbacher, PhD · 720-857-5105 · todd.furbacher@va.gov
Study contacts (from the official record)
- Sarah J Wherry, PhD · (720) 848-6475 · sarah.wherry@va.gov
- Toby Wellington, MS · (720) 848-6376 · toby.wellington@va.gov
Similar studies in Colorado
All healthy volunteers studies in Colorado →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Aurora, CO + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Aurora, CO + 18 other US sites
- Eligibility basics
- Ages 18–100